Group One Trading’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-1,284
Closed -$7.38K – 8234
2026
Q1
$8.06K Sell
1,284
-6,767
-84% -$62.8K ﹤0.01% 6480
2025
Q4
$98.7K Sell
8,051
-1,623
-17% -$26.5K ﹤0.01% 5024
2025
Q3
$198K Sell
9,674
-8,328
-46% -$132K ﹤0.01% 4672
2025
Q2
$243K Buy
+18,002
New +$197K ﹤0.01% 4146
2025
Q1
– Sell
-6,244
Closed -$38.2K – 8154
2024
Q4
$30.3K Sell
6,244
-2,482
-28% -$13.9K ﹤0.01% 5429
2024
Q3
$67.4K Buy
8,726
+6,565
+304% +$58.4K ﹤0.01% 4450
2024
Q2
$21.6K Sell
2,161
-9,057
-81% -$99.5K ﹤0.01% 5169
2024
Q1
$136K Buy
+11,218
New +$163K ﹤0.01% 3875
2022
Q2
– Sell
-89,933
Closed -$2.66M – 8312
2022
Q1
$3.39M Buy
+89,933
New +$3.98M ﹤0.01% 1873
2020
Q2
– Sell
-3,657
Closed -$39.8K – 6066
2020
Q1
$33K Sell
3,657
-6,740
-65% -$63.9K ﹤0.01% 3972
2019
Q4
$107K Buy
+10,397
New +$118K ﹤0.01% 3594

Other funds holding OPRX

Group One Trading's OPRX Position: Q2 2026 in Review

Group One Trading sold out of OptimizeRx (OPRX) in Q2 2026, closing a stake of 1,284 shares — an estimated $7.38K sold.

Group One Trading first reported a position in OPRX in Q4 2019 and held it in 11 quarters. The position peaked at $3.39M in Q1 2022. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Group One Trading reported no remaining OptimizeRx position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 1,284 OptimizeRx shares in Q2 2026, an estimated $7.38K.
  • Group One Trading first reported a position in OptimizeRx in Q4 2019 and held it in 11 quarters.
  • Group One Trading's OptimizeRx position peaked at $3.39M in Q1 2022.
  • 112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.